EcoDrugPlus

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSELUG00000000414
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase

Ensembl ID : ENSELUG00000015999
Gene Symbol: GLS
4 Cross references
228 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSELUG00000016228
Gene Symbol: LOC105022529
3 Cross references
236 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSELUG00000019437
Gene Symbol: GSTP1
3 Cross references
161 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSELUG00000020954
Gene Symbol: LOC105029759
3 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSELUG00000018799
Gene Symbol: LOC105029783
3 Cross references
189 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSELUG00000011750
Gene Symbol: LOC105031009
3 Cross references
199 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor

Ensembl ID : ENSELUG00000013712
Gene Symbol: LOC105012724
3 Cross references
174 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSELUG00000008526
Gene Symbol: LOC105031062
2 Cross references
191 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSELUG00000019758
Gene Symbol: LOC105011524
2 Cross references
1126 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSELUG00000000074
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1

Ensembl ID : ENSELUG00000007817
Gene Symbol: LOC105019793
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).